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Abstract
The use of high-throughput screening allowed for the optimization of reaction conditions for the
palladium-catalyzed asymmetric decarboxylative alkylation reaction of enolate-stabilized enol
carbonates. Changing to a non-polar reaction solvent and to an electron-deficient PHOX derivative
as ligand from our standard reaction conditions improved the enantioselectivity for the alkylation of
a ketal-protected,1,3-diketone-derived enol carbonate from 28% ee to 84% ee. Similar improvements
in enantioselectivity were seen for a β-keto-ester derived- and an α-phenyl cyclohexanone-derived
enol carbonate.
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New methods for the construction of highly substituted carbocycles with defined
stereochemistry are important for the synthesis of natural products and pharmaceutical agents.
1 Although automation is well-established within the pharmaceutical industry for the rapid
synthesis of new chemical entities, identification of biological activity via screening, and
process optimization,2 less work has been performed within the academic community utilizing
automation.3 Similarly, the identification of efficient catalysts and their associated optimized
reaction conditions, which cannot usually be predicted, often necessitates high-throughput
methods to perform the required time- and labor-intensive screening.4 Herein we report the
optimization of the Pd-catalyzed, asymmetric decarboxylative alkylation5 of enolate-stabilized
enol carbonates for the synthesis of all-carbon quaternary stereocenters through automated
high-throughput screening of reaction conditions.
Enol carbonate 1, derived from 2-methyl cyclohexa-1,3-dione, was selected as our substrate
for the asymmetric Pd-catalyzed decarboxylative alkylation reaction (Scheme 1). Enol
carbonate 1 was synthesized from known mono-ketal 26 via deprotonation with NaH in THF
at 60 °C and trapping of the resulting thermodynamic enolate with allyl chloroformate in 69%
yield. Interestingly, ketal-opened product 3 was also formed in 12% yield, suggesting that Pd-
catalyzed enantioselective formation of the quaternary stereocenter of 4 from 1 may be in
competition with ketal-ring opening. Exposure of 1 to our standard decarboxylative alkylation
conditions (Pd2dba3 and (S)-t-BuPHOX in THF at 25 °C)7 resulted in formation of 48 in 62%
yield. Allyl ketone 4 required derivatization to ene-dione 5 via Ru-catalyzed metathesis9 with
methyl acrylate and Grubbs' 2nd generation catalyst 6 in order to determine the enantiomeric
excess of the product from the asymmetric alkylation reaction.
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Chiral HPLC analysis of 5 showed that the desired quaternary stereocenter-containing product
was formed in a poor 28% ee under our standard reaction conditions.
In order to obtain ketone 4 with high levels of enantioselectivity, we conducted high-
throughput, parallel screening to determine the required catalyst and reaction conditions.
Experiments were conducted in 1 mL vials within 96-well microtiter plates using a Symyx™
Technologies (Santa Clara, CA) Core Module housed in a Braun N2-filled glovebox. A stock
solution of substrate 1 in THF was added to each capped vial charged with Pd2dba3 and (S)-t-
BuPHOX in the appropriate solvent(s). After 48 h at 30 °C, the reactions were diluted with
hexane and purified via parallel silica gel chromatography using a Code Module housed in a
fume hood. The resulting purified alkylated products 4 were subjected to Ru-catalyzed
metathesis with excess methyl acrylate to afford 5, which was then analyzed by chiral SFC for
enantiomeric excess. As an initial screen, we investigated enantioselectivity as a function of
reaction solvent (Table 1). Modification of our standard reaction conditions to lower catalyst
loadings and slightly higher reaction temperature (30 °C) improved enantioselectivity to 40%
ee (entry 1) from 28% ee (Scheme 1). Reactions conducted in ethereal and polar solvents
(entries 1-6) gave low levels of enantioselectivity. Similarly, polar aromatic solvents gave the
poorest ee's (entries 7 and 8). The best enantioselectivities were observed with the use of non-
polar aromatic reaction solvents (entries 9 and 10), with the use of hexane as a co-solvent
improving enantioselectivity up to 64% ee (entry 12). It is important to note that the use of
hexane as the only solvent resulted in no reaction, as the Pd-catalyst precipitated from the
reaction mixture.
We believe that the use of a non-polar solvent (mixture) produces a higher affinity between
the chiral Pd-center and the intermediate enolate than when the reaction is conducted in polar
solvents.10
In order to improve enantioselectivity in the asymmetric Pd-catalyzed decarboxylative
alkylation of 1 to synthetically useful levels, we performed a screen of various ligands. Our
ligand search was biased toward the PHOX ligand class, as these have proven especially
effective in related reactions and are readily prepared and modified.11 The ligands employed
in the screen are depicted in Figure 1 and the reactions conducted in THF, diethyl ether, toluene,
and a 2:1 mixture of hexane and toluene solvents are shown in Figure 2. The highest levels of
enantioselectivity were observed with the use of t-BuPHOX ligands (L1-L8) and with the use
of a 2:1 hexane and toluene solvent mixture. Ligand L9, which does not possess a phosphine,
did not yield product. Similarly, PHOX ligands having a third, hetero-atomic chelating group
(L10-L12) resulted in low yields and very low ee's (< 20% ee). Interestingly, ligand L13, the
silyl-protected derivative of L12, afforded product in 61% ee in the opposite enantiomer of
that produced with (S)-t-BuPHOX, L1. Cyclohexyldiamine-derived ligands L23 and L24,
which have shown great synthetic use in other asymmetric alkylation reactions,12 afforded 5
in enantiomeric excesses under 10% ee.13 Although the sterically encumbered naphthyl- and
mesityl-derived phosphines L5 and L6 decreased enantioselection, electron-deficient t-
BuPHOX derivatives L7 and L8 gave ee's of 82% and 79%, respectively, in 2:1 hexane and
toluene as solvent. Interestingly, the monomethoxylated t-BuPHOX derivative L2 afforded
product in only 46% ee in the non-polar solvent mixture, suggesting that ligand electronics
greatly affect enantioselection. It is hypothesized that, like the less polar solvent(s) in Table 1,
the highly electron-deficient phosphine ligands (L7 and L8) create a more-tightly associated
Pd-PHOX ligand complex, resulting in higher enantioselectivities.7d
We screened other highly electron-deficient PHOX ligands (Figure 3), as well as re-screened
the ligands which gave the highest levels of enantioselectivity within the first ligand screen,
in order to test whether even more-highly electron-deficient PHOX-derivatives could improve
the enantioselectivity of the Pd-catalyzed decarboxylative alkylation reaction of 1 (Table 2).
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The highest levels of enantioselection were achieved with the trifluoromethylated t-BuPHOX
derivative L2511,14 in the 2:1 hexane and toluene mixture (entry 6). It is not too surprising
that ligand L25 was found to be the best ligand with respect to enantioselectivity, as it has been
shown to give the highest levels of enantioselection for the asymmetric alkylation of
ketones15 and for an asymmetric alkylation within the our formal synthesis of hamigeran B.16
Simultaneous screening of the enantioselective alkylation of enolate-stabilized enol carbonates
7 and 8 revealed improved enantioselectivities from our standard reaction conditions with the
use of electron-deficient ligands in the non-polar hexane and toluene solvent mixture (Scheme
2).17 Exposure of β-keto ester-derived enol carbonate 7 to the decarboylative alkylation catalyst
derived from L8 in 2:1 hexane and toluene improved the enantioselectivity for the formation
of 918 to 71% ee from 24% ee when using (S)-t-BuPHOX in THF.17 Similarly α-phenyl
cyclohexanone-derived enol cabonate 8 afforded allyl ketone 1019 in 51% ee when exposed to
the catalyst derived from L31 in the non-polar solvent mixture, an improvement from 11% ee
when (S)-t-BuPHOX is utilized in THF.17
In summary, we have used high-throughput screening for the asymmetric, Pd-catalyzed
decarboxylative alkylation reaction of enolate-stabilized enol carbonates to afford quaternary
stereocenter-containing products with high levels of enantioselection. The high-throughput
screening of various solvents and ligands allowed us to improve the enantioselectivities with
the use of a non-polar solvent mixture (2:1 hexanes and toluene) and electron-deficient t-
BuPHOX derivatives.
Experimental Data
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (at 300 MHz and 75 MHz
respectively) and are reported relative to residual CHCl3 (δ 7.26 and 77.0 ppm). IR spectra
were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of
absorption (cm−1). High-resolution mass spectra were recorded on a Agilent 6200 Series Time-
of-Flight LC/MS/TOF system with a Agilent G1978A Multimode source in electrospray
ionization (ESI) mode. Analytical chiral HPLC for 5 was performed with an Agilent 1100
Series HPLC utilizing a Chiralcel OD-H column with visualization at 254 nm and a 1 mL/min
flow rate of 10% i-PrOH/90% hexane. Analytical chiral SFC for 5 was performed with a Mettler
supercritical CO2 analytical chromatography system utilizing a Chiralcel AD-H column with
visualization at 254 nm and a 3 mL/min flow rate of 2% i-PrOH/2% CH3CN/96% CO2.
Representative Screening Procedure
To 1 mL vials in a 96-well microtiter plate was added 59 μL of a Pd2dba3 solution (0.0025 M
in THF) using a Symyx Core Module within a nitrogen-filled glove box. The Pd2dba3 solutions
were evaporated to dryness under reduced pressure using a Genevac centrifugal evaporator
within the glove box. To the dried vials charged with Pd2dba3 was added 113 μL of the desired
solvent to be screened and 18.8 μL of the desired ligand solution (0.02 M in THF). To the catalyst
solutions, which had been stirred at 30°C for 30 min, was added 30 μL of an enol carbonate
1 solution (0.2 M in THF) and 38 μL of the same solvent to be screened. The reactions were
stirred at 30 °C for 48 h. The crude reactions were purified via parallel silica gel
chromatography, eluted with hexane: ethyl acetate = 5:1, using a Symyx Core Module within
a fume hood. The fractions containing purified 4 were evaporated to dryness using using a
Genevac centrifugal evaporator.
To each of the 1 mL vials containing purified 4 was added 50 μL of a methyl acrylate solution
(0.9 M in CH2Cl2) and 50 μL of a Grubbs' 2nd generation Ru-catalyst 6 solution (0.0055 M in
CH2Cl2) using a Symyx Core Module within a nitrogen-filled glove box. After stirring at 30
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°C for 3 h, the crude reactions were again purified via parallel silica gel chromatography, eluted
with hexane: ethyl acetate = 3:1, using a Symyx Core Module within a fume hood. The solutions
of purified product 5 were directly subjected to chiral SFC analysis to determine % ee.
Selected Spectroscopic Data
Allyl (6-methyl-1,4-dioxaspiro[4.5]dec-6-en-7-yl) carbonate (1)
1H-NMR (300 MHz, CDCl3) δ 5.95 (dddd, J = 18.6, 10.5, 5.7, 5.7 Hz, 1H), 5.38 (ddd, J = 18.6,
2.7, 1.5 Hz, 1H), 5.29 (ddd, J = 10.5, 2.7, 1.5 Hz, 1H), 4.65 (ap dt, J = 5.7, 1.2 Hz, 2H), 3.97-4.03
(m, 4H), 2.20-2.27 (m, 2H), 1.70-1.84 (m, 4H), 1.58 (t, J = 1.9 Hz, 3H); 13C-NMR (75.0 MHz,
CDCl3) δ 152.1, 147.9, 131.2, 122.7, 118.9, 108.4, 68.6, 65.2, 33.0, 26.7, 19.4, 8.4; IR (thin
film) 2952, 2884, 1756, 1700, 1442, 1366, 1346, 1235, 1114, 1036, 993; HRMS (ESI)
calculated for C14H19O5 [M+H]+ 255.1227, found 255.1240.
(E)-Methyl 4-(6-methyl-7-oxo-1,4-dioxaspiro[4.5]decan-6-yl)but-2-enoate (5)
1H-NMR (300 MHz, CDCl3) δ 6.92 (ddd, J = 15.3, 6.9, 6.9 Hz, 1H), 5.80 (d, J = 15.3 Hz, 1H),
3.91-3.98 (m, 4H), 3.70 (s, 3H), 2.66 (dd, J = 14.7, 6.9 Hz, 1H), 2.39-2.53 (m, 2H), 2.36 (dd,
J = 14.7, 6.9 Hz, 1H), 1.89-1.94 (m, 2H), 1.73-1.84 (m 2H), 1.16 (s, 3H); 13C-NMR (75.0
MHz, CDCl3) δ 210.8, 166.5, 145.9, 113.1, 65.1, 64.9, 58.1, 51.3, 36.9, 35.8, 29.5, 19.1, 17.1;
IR (thin film) 2954, 2890, 1714, 1654, 1436, 1335, 1273, 1177, 1072, 1030; HRMS (ESI)
calculated for C14H21O5 [M+H]+ 269.1384, found 269.1382. Chiral HPLC tRmajor: 25.3 min.
tR minor: 34.6 min. Chiral SFC tR major: 10.8 min. tR minor: 11.8 min.
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Figure 1.
Ligands screened in the Pd-catalyzed decarboxylative alkylation reaction of 1
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Figure 2.
Dependence of enantiomeric excess of 5 on ligand structure and solvent in the decarboxylative
alkylation reaction of 1
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Figure 3.
Ligands screened in the Pd-catalyzed decarboxylative alkylation reaction of 1
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Scheme 1.
Preparation of 5 from 2 via asymmetric decarboxylative alkylation
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Scheme 2.
Asymmetric Pd-catalyzed decarboxylative alkylation reactions of enolate-stabilized enol
carbonates 7 and 8
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Table 1
Evaluation of Reaction Solvent
Entry Solvent ee (%)a
1 THF 40
2 Et2O 45
3 t-BuOCH3 49
4 DME 30
5 p-dioxane 21
6 EtOAc 27
7 PhF 19
8 PhCl 19
9 PhH 55
10 PhCH3 59
11 Hex:PhCH3 (1:1) 61
12 Hex:PhCH3 (2:1) 64
a
Enantiomer excesses determined via chiral SFC analysis of chromatographically-purified product 5.
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Table 2
Evaluation of Reaction Ligands
Entry Ligand ee (%)a
1 L1 64
2 L3 58
3 L4 55
4 L7 82
5 L8 79
6 L25 84
7 L26 72
8 L27 74
9 L28 72
10 L29 58
11 L30 74
12 L31 70
a
Enantiomer excesses determined via chiral SFC analysis of chromatographically-purified product 5.
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